PatrickJLoehrerSr.MD

Oncology • Indianapolis, IN

Gastrointestinal Cancer, Hematologic Oncology

Professor, Oncology, Indiana University School of Medicine

Join to view full profile

Dr. Loehrer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Loehrer's full profile

Already have an account?

Office
535 Barnhill Dr
# ROUTE448
Indianapolis, IN 46202
Phone+1 317-278-7418

Summary

I am a board certified medical oncologist specializing in Gastrointestinal and thymic malignancies. I also am involved with global oncology

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1981 - 1983
Rush University Medical CenterResidency, Internal Medicine, 1978 - 1980
Rush Medical College of Rush University Medical CenterClass of 1978

Certifications & Licensure

IN State Medical License 1981 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Indianapolis Monthly Castle Connolly, 2010-2011, 2013
Fellow (FASCO) American Society of Clinical Oncologists, 2008
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Start of enrollment: 1994 Sep 01
Completed
Phase 3
Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer Start of enrollment: 1999 Feb 01
Completed
Phase 2
Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma Start of enrollment: 2001 Jun 19
Completed
Phase 2
Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Start of enrollment: 2003 Aug 29
Completed
Phase 3
Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma Start of enrollment: 2005 Jan 01
Completed
Phase 2
Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma Start of enrollment: 2006 Apr 01
Completed
Phase 1
Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer Start of enrollment: 2007 Feb 28
Completed
Phase 2
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer Start of enrollment: 2006 Aug 01
Completed
Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer Start of enrollment: 2008 Jun 01
Terminated
Phase 2
Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps Start of enrollment: 2009 Jan 01
Completed
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies Start of enrollment: 2011 Jun 01
Completed
Phase 2
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
Active, not recruiting
Phase 2, Phase 3
A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas Start of enrollment: 2014 Oct 01
Completed
Phase 2
Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2017 Oct 13
Terminated
Phase 2
Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women Start of enrollment: 2021 Nov 18
Recruiting
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) Start of enrollment: 2019 Sep 11
Terminated
Phase 1
Join now to see all

Publications & Presentations

PubMed

Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training From ASCO.
Maria T Bourlon, Ami S Bhatt, Gilberto Lopes, Fredrick Chite Asirwa, Alexandru E Eniu
JCO Global Oncology. 2024-04-01
Expanding Myeloma Training and Care in Western Kenya Through the ECHO Model: The Pilot Phase.
Mercy Atieno Oduor, Teresa Cherop Lotodo, Tyler Severance, Beatrice Jepngetich Melly, Austin Omondi
JCO Global Oncology. 2024-04-01
3 citations
Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
Aristine Cheng, Anuj Kashyap, Helene Salvator, Lindsey B Rosen, Devon Colby
The New England Journal of Medicine. 2024-03-21

Press Mentions

Empowering People with Cancer: A Q&A with Cancer.Net Editor in Chief Dr. Jyoti PatelJune 8th, 2021
Once-Trumpeted $150M Simon Cancer Center to Be Empty by 2026September 12th, 2020
Indiana University School of Medicine Researchers Use Cutting-Edge Technology to Predict Which Triple Negative Breast Cancer Patients May Avoid Recurrence and Those Who Are at High-Risk of RelapseDecember 16th, 2019
Join now to see all

Grant Support

Eastern Cooperative Oncology GroupNational Cancer Institute1994–2012
Indiana University Melvin And Bren Simon Cancer Center Support GrantNational Cancer Institute2008–2011
Usa/Japan--Oral Uracil/Ftorafur+ Leucovorin In ColorectaNational Center For Research Resources2000–2002
Perillyl Alcohol In Resectable Pancreatic CancerNational Center For Research Resources2000–2002
LY231514 (Thymidylate Synthase Inhibitor) With Pancreatic CancerNational Center For Research Resources1996–1997